Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

J&J says real-world data finds no amputation risk for Invokana

Hopes the new data will persuade regulators to ease off warnings on the franchise

What pharma marketers can learn from growth hacking?

Growth hackers instinctively blend technical skills with creative thinking

An agency called Owen

- PMLiVE

The Creative Floor Healthcare awards open for entry

Introduces a new animal health category

‘How is your day?’

The initiative that shows how plasma protein therapies improve lives

The year of the blockbuster

Tracking the paths of the 12 drugs launching in 2018 that  are projected to reach blockbuster status

Genetic testing: nothing to write home about?

An issue of health literary and health motivation?

- PMLiVE

Advancing women in healthcare

Fostering the next generation of leaders

Patient engagement hygiene factors

Ignore them at your peril

- PMLiVE

Heron boosted by new data for ‘breakthrough’ pain drug

Shares jumped by a third after trial announcement

- PMLiVE

Another R&D flop for Incyte, but Jakafi keeps delivering

Jakafi achieved overall response rate of 55% on organ transplant patients who developed GVHD

- PMLiVE

Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK’s Sanofi’s Dupixent and more

The latest news from across pharma, biotech and healthcare

- PMLiVE

Roche reshuffles its executive committee, again

Sophie Kornowski-Bonnet joins Reed and heads for the exit

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links